Correction to: Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1750-1172

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Correction to: Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm ; volume:14 ; number:1 ; day:21 ; month:5 ; year:2019 ; pages:1 ; date:12.2019
Orphanet journal of rare diseases ; 14, Heft 1 (21.5.2019), 1, 12.2019

Creator: Sekijima, Yoshiki
Ueda, Mitsuharu
Koike, Haruki
Misawa, Sonoko
Ishii, Tomonori
Ando, Yukio

Contributor: SpringerLink (Online service)

DOI: 10.1186/s13023-019-1092-7

URN: urn:nbn:de:101:1-2019102220212651330445

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:24 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Sekijima, Yoshiki
Ueda, Mitsuharu
Koike, Haruki
Misawa, Sonoko
Ishii, Tomonori
Ando, Yukio
SpringerLink (Online service)

Other Objects (12)

Vasculopathy in transthyretin Val30Met familial amyloid polyneuropathy

Ocular manifestations of transthyretin-related familial amyloid polyneuropathy

Psychopathological Dimensions in Portuguese Subjects with Transthyretin Familial Amyloid Polyneuropathy

Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm

Brazilian consensus for diagnosis, management and treatment of transthyretin familial amyloid polyneuropathy

Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy

Positive real-world effectiveness of tafamidis for delaying disease progression in transthyretin familial amyloid polyneuropathy

Epidemiology of Familial Amyloid Polyneuropathy in Bulgaria

Preimplantation genetic testing for familial amyloid polyneuropathy

Epidemiology of transthyretin-associated familial amyloid polyneuropathy in the Majorcan area: Son Llàtzer Hospital descriptive study

Transthyretin familial amyloid polyneuropathy (TTR-FAP) in Mallorca: a comparison between late- and early-onset disease

Patient-reported outcomes on familial amyloid polyneuropathy (FAP)

Vasculopathy in transthyretin Val30Met familial amyloid polyneuropathy

Ocular manifestations of transthyretin-related familial amyloid polyneuropathy

Psychopathological Dimensions in Portuguese Subjects with Transthyretin Familial Amyloid Polyneuropathy

Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm

Brazilian consensus for diagnosis, management and treatment of transthyretin familial amyloid polyneuropathy

Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy

Positive real-world effectiveness of tafamidis for delaying disease progression in transthyretin familial amyloid polyneuropathy

Epidemiology of Familial Amyloid Polyneuropathy in Bulgaria

Preimplantation genetic testing for familial amyloid polyneuropathy

Epidemiology of transthyretin-associated familial amyloid polyneuropathy in the Majorcan area: Son Llàtzer Hospital descriptive study

Transthyretin familial amyloid polyneuropathy (TTR-FAP) in Mallorca: a comparison between late- and early-onset disease

Patient-reported outcomes on familial amyloid polyneuropathy (FAP)

Vasculopathy in transthyretin Val30Met familial amyloid polyneuropathy

Ocular manifestations of transthyretin-related familial amyloid polyneuropathy

Psychopathological Dimensions in Portuguese Subjects with Transthyretin Familial Amyloid Polyneuropathy

Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm

Brazilian consensus for diagnosis, management and treatment of transthyretin familial amyloid polyneuropathy

Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy

Positive real-world effectiveness of tafamidis for delaying disease progression in transthyretin familial amyloid polyneuropathy

Epidemiology of Familial Amyloid Polyneuropathy in Bulgaria

Preimplantation genetic testing for familial amyloid polyneuropathy

Epidemiology of transthyretin-associated familial amyloid polyneuropathy in the Majorcan area: Son Llàtzer Hospital descriptive study

Transthyretin familial amyloid polyneuropathy (TTR-FAP) in Mallorca: a comparison between late- and early-onset disease

Patient-reported outcomes on familial amyloid polyneuropathy (FAP)

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Correction to: Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Vasculopathy in transthyretin Val30Met familial amyloid polyneuropathy

Ocular manifestations of transthyretin-related familial amyloid polyneuropathy

Psychopathological Dimensions in Portuguese Subjects with Transthyretin Familial Amyloid Polyneuropathy

Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm

Brazilian consensus for diagnosis, management and treatment of transthyretin familial amyloid polyneuropathy

Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy

Positive real-world effectiveness of tafamidis for delaying disease progression in transthyretin familial amyloid polyneuropathy

Epidemiology of Familial Amyloid Polyneuropathy in Bulgaria

Preimplantation genetic testing for familial amyloid polyneuropathy

Epidemiology of transthyretin-associated familial amyloid polyneuropathy in the Majorcan area: Son Llàtzer Hospital descriptive study

Transthyretin familial amyloid polyneuropathy (TTR-FAP) in Mallorca: a comparison between late- and early-onset disease

Patient-reported outcomes on familial amyloid polyneuropathy (FAP)

Vasculopathy in transthyretin Val30Met familial amyloid polyneuropathy

Ocular manifestations of transthyretin-related familial amyloid polyneuropathy

Psychopathological Dimensions in Portuguese Subjects with Transthyretin Familial Amyloid Polyneuropathy

Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm

Brazilian consensus for diagnosis, management and treatment of transthyretin familial amyloid polyneuropathy

Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy

Positive real-world effectiveness of tafamidis for delaying disease progression in transthyretin familial amyloid polyneuropathy

Epidemiology of Familial Amyloid Polyneuropathy in Bulgaria

Preimplantation genetic testing for familial amyloid polyneuropathy

Epidemiology of transthyretin-associated familial amyloid polyneuropathy in the Majorcan area: Son Llàtzer Hospital descriptive study

Transthyretin familial amyloid polyneuropathy (TTR-FAP) in Mallorca: a comparison between late- and early-onset disease

Patient-reported outcomes on familial amyloid polyneuropathy (FAP)

Vasculopathy in transthyretin Val30Met familial amyloid polyneuropathy

Ocular manifestations of transthyretin-related familial amyloid polyneuropathy

Psychopathological Dimensions in Portuguese Subjects with Transthyretin Familial Amyloid Polyneuropathy

Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm

Brazilian consensus for diagnosis, management and treatment of transthyretin familial amyloid polyneuropathy

Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy

Positive real-world effectiveness of tafamidis for delaying disease progression in transthyretin familial amyloid polyneuropathy

Epidemiology of Familial Amyloid Polyneuropathy in Bulgaria

Preimplantation genetic testing for familial amyloid polyneuropathy

Epidemiology of transthyretin-associated familial amyloid polyneuropathy in the Majorcan area: Son Llàtzer Hospital descriptive study

Transthyretin familial amyloid polyneuropathy (TTR-FAP) in Mallorca: a comparison between late- and early-onset disease

Patient-reported outcomes on familial amyloid polyneuropathy (FAP)

Related objects

Reset password